These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 19684197)

  • 1. Fallacies in clinical cardiovascular trials.
    Swedberg K
    Heart; 2009 Sep; 95(17):1464-8. PubMed ID: 19684197
    [No Abstract]   [Full Text] [Related]  

  • 2. An orwellian discourse on the meaning and measurement of noninferiority.
    Diamond GA; Kaul S
    Am J Cardiol; 2007 Jan; 99(2):284-7. PubMed ID: 17223435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International differences in treatment effects in cardiovascular clinical trials.
    O'Shea JC; Califf RM
    Am Heart J; 2001 May; 141(5):875-80. PubMed ID: 11320382
    [No Abstract]   [Full Text] [Related]  

  • 4. Making sense of noninferiority: a clinical and statistical perspective on its application to cardiovascular clinical trials.
    Kaul S; Diamond GA
    Prog Cardiovasc Dis; 2007; 49(4):284-99. PubMed ID: 17185116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statistical issues in interpreting clinical trials.
    DeMets DL
    J Intern Med; 2004 May; 255(5):529-37. PubMed ID: 15078496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-inferiority study design: lessons to be learned from cardiovascular trials.
    Head SJ; Kaul S; Bogers AJ; Kappetein AP
    Eur Heart J; 2012 Jun; 33(11):1318-24. PubMed ID: 22564354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should subgroup analysis of randomized clinical trials have a direct impact on clinical practice?
    Bria E; Di Maio M; Cuppone F; Nisticò C; Cognetti F; Giannarelli D
    J Clin Oncol; 2007 Feb; 25(5):605-6; author reply 606-7. PubMed ID: 17290074
    [No Abstract]   [Full Text] [Related]  

  • 8. Issues in the planning and conduct of randomised trials.
    Bhandari M; Pape HC; Giannoudis PV
    Injury; 2006 Apr; 37(4):349-54. PubMed ID: 16487524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limitations of randomized clinical trials in chronic diseases: explanations and recommendations.
    Pincus T
    Adv Mind Body Med; 2002; 18(2):14-21. PubMed ID: 12629874
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparing outcomes on peritoneal and hemodialysis: a case study in the interpretation of observational studies.
    Davies SJ
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):24-30. PubMed ID: 17237887
    [No Abstract]   [Full Text] [Related]  

  • 11. Interpretation and inference in noninferiority randomized controlled trials in drug research.
    Wangge G; Klungel OH; Roes KC; de Boer A; Hoes AW; Knol MJ
    Clin Pharmacol Ther; 2010 Sep; 88(3):420-3. PubMed ID: 20668448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reflections on early stopping of a clinical trial.
    Armstrong PW; Granger CB
    Am Heart J; 2006 Sep; 152(3):407-9. PubMed ID: 16923403
    [No Abstract]   [Full Text] [Related]  

  • 13. ALS issues in clinical trials. Missing data.
    Thompson JL; Levy G
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():48-51. PubMed ID: 15512872
    [No Abstract]   [Full Text] [Related]  

  • 14. Beyond the randomized clinical trial: the role of effectiveness studies in evaluating cardiovascular therapies.
    Nallamothu BK; Hayward RA; Bates ER
    Circulation; 2008 Sep; 118(12):1294-303. PubMed ID: 18794402
    [No Abstract]   [Full Text] [Related]  

  • 15. Korn and Freidlin's misunderstanding of the null hypothesis significance testing procedure.
    Trafimow D; Rice S
    Am J Bioeth; 2011 Mar; 11(3):15-6. PubMed ID: 21400377
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tricks, devices, expedients and stratagems in the management and interpretation of cardiological trials].
    Frea S; Bobbio M
    G Ital Cardiol (Rome); 2006 Nov; 7(11):761-7. PubMed ID: 17216918
    [No Abstract]   [Full Text] [Related]  

  • 17. Dual randomization in cardiovascular trials.
    Califf RM
    Am Heart J; 2000 Jul; 140(1):1. PubMed ID: 10874250
    [No Abstract]   [Full Text] [Related]  

  • 18. The several faces of clinical trials: from new therapies to failed preventive strategies.
    Fuster V
    Nat Clin Pract Cardiovasc Med; 2006 Apr; 3(4):173. PubMed ID: 16568110
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical trials and rare diseases.
    Lagakos SW
    N Engl J Med; 2003 Jun; 348(24):2455-6. PubMed ID: 12802033
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical trials methodology: randomization, intent-to-treat, and random-effects regression.
    Atkins DC
    Depress Anxiety; 2009; 26(8):697-700. PubMed ID: 19658122
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.